Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 6;71(5):653-673.
doi: 10.1016/j.molcel.2018.08.005.

Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease

Affiliations
Free article
Review

Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease

John E Burke. Mol Cell. .
Free article

Abstract

Lipid phosphoinositides play fundamental roles in virtually all pathways that control a cell's decision to grow, move, divide, and die. Because of this, kinases that phosphorylate phosphoinositide lipids are critically involved in myriad essential functions including growth, development, and membrane trafficking. The misregulation of phosphoinositide kinases is critical in human diseases, including cancer, primary immunodeficiencies, and developmental disorders. Phosphoinositide kinases also play a role in mediating bacterial and viral infections for many potent human pathogens. Furthermore, inhibitors of parasite phosphoinositide kinases are in development as therapies for both malaria and cryptosporidiosis. Therefore, understanding how phosphoinositide kinases are regulated has implications for the treatment of many devastating human diseases. Recent structures of phosphoinositide kinases have revealed unique molecular insight into their regulation. This review will summarize our current molecular knowledge on phosphoinositide kinase regulation, and how this information is being used to generate novel small molecule inhibitors as potential therapeutics.

Keywords: PI3K; PI4KA; PI4KB; PI4P5KA; PI5P4KB; PI5P4KC; PIK3CA; PIK3CD; X-ray crystallography; autophagy; cancer; kinase inhibitors; lipid signaling; oncogenes; phosphatidylinositol 4 kinase; phosphoinositide 3 kinase; phosphoinositides; primary immunodeficiency.

PubMed Disclaimer

Publication types

MeSH terms

Substances

Grants and funding